Beech Hill Advisors Inc. Has $2.45 Million Stake in Kenvue Inc. (NYSE:KVUE)

Beech Hill Advisors Inc. cut its position in shares of Kenvue Inc. (NYSE:KVUE) by 2.7% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 105,894 shares of the company’s stock after selling 2,968 shares during the quarter. Beech Hill Advisors Inc.’s holdings in Kenvue were worth $2,449,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the company. Culbertson A N & Co. Inc. increased its holdings in Kenvue by 40.5% in the third quarter. Culbertson A N & Co. Inc. now owns 16,300 shares of the company’s stock worth $377,000 after purchasing an additional 4,700 shares in the last quarter. Wolff Wiese Magana LLC grew its position in shares of Kenvue by 0.7% during the 3rd quarter. Wolff Wiese Magana LLC now owns 76,999 shares of the company’s stock worth $1,781,000 after buying an additional 501 shares during the period. LaFleur & Godfrey LLC increased its stake in shares of Kenvue by 12.5% in the 3rd quarter. LaFleur & Godfrey LLC now owns 62,650 shares of the company’s stock valued at $1,449,000 after acquiring an additional 6,985 shares in the last quarter. Vontobel Holding Ltd. lifted its position in shares of Kenvue by 13.4% during the 3rd quarter. Vontobel Holding Ltd. now owns 22,594 shares of the company’s stock valued at $523,000 after acquiring an additional 2,677 shares during the period. Finally, Cornell Pochily Investment Advisors Inc. bought a new position in Kenvue during the third quarter worth $215,000. Institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have weighed in on the stock. UBS Group lifted their price target on shares of Kenvue from $20.00 to $22.00 and gave the company a “neutral” rating in a research note on Wednesday, August 7th. Royal Bank of Canada downgraded Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target on the stock. in a research note on Tuesday, September 24th. Deutsche Bank Aktiengesellschaft raised their price objective on Kenvue from $23.00 to $24.00 and gave the company a “buy” rating in a research note on Wednesday, August 7th. Jefferies Financial Group began coverage on Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 target price on the stock. Finally, JPMorgan Chase & Co. increased their target price on Kenvue from $24.00 to $25.00 and gave the stock an “overweight” rating in a report on Friday, October 11th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $22.20.

Kenvue Trading Down 0.1 %

Shares of Kenvue stock opened at $21.73 on Thursday. The company has a current ratio of 0.99, a quick ratio of 0.68 and a debt-to-equity ratio of 0.69. The stock has a fifty day simple moving average of $22.24 and a 200 day simple moving average of $20.19. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $23.55. The company has a market capitalization of $41.61 billion, a P/E ratio of 27.86, a price-to-earnings-growth ratio of 2.76 and a beta of 1.40.

Kenvue (NYSE:KVUE) last posted its earnings results on Tuesday, August 6th. The company reported $0.32 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.28 by $0.04. Kenvue had a net margin of 7.23% and a return on equity of 21.80%. The firm had revenue of $4 billion during the quarter, compared to analyst estimates of $3.93 billion. During the same quarter in the prior year, the business posted $0.32 EPS. The business’s revenue was down .3% compared to the same quarter last year. On average, sell-side analysts anticipate that Kenvue Inc. will post 1.08 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Wednesday, November 27th. Shareholders of record on Wednesday, November 13th will be given a dividend of $0.205 per share. This represents a $0.82 annualized dividend and a dividend yield of 3.77%. Kenvue’s dividend payout ratio is currently 105.13%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.